Article Text

Download PDFPDF

136 Care of patients with progressive supranuclear palsy in the hospice setting: an audit
  1. Kate Hoddell,
  2. Laura Dewhirst and
  3. Derek Willis
  1. Severn Hospice


Hospices are increasingly focused on improving services for patients with life-limiting non-malignant conditions. Progressive supranuclear palsy (PSP) is a life-limiting progressive neurological disease which can be mistaken for Parkinson's disease early in its course. Symptoms progress rapidly within 5–7 years. Patients with PSP may have a high number of symptoms and will have a poor prognosis.

This retrospective audit aimed to evaluate care provided to patients with PSP referred to Severn Hospice using the guide 'Pathway of Care for PSP: A guide for Health and Social Care Professionals' as the standard. It included all patients under hospice care since 2015.

20 patients were included, 8 of whom continued under hospice care. 7 patients had died and 5 discharged. Time between diagnosis and referral to our service was usually in the first year. Most patients were referred for 'medical assessment and support' and had more than 3 symptoms at referral. 5 patients were admitted to the hospice, 3 of whom died during admission. These patients had at least 4 symptoms at referral.

7 patients had no advance care planning (ACP) completed (defined as a do not resuscitate order (DNAR), preferred place of care (PPC), preferred place of death (PPD) and/or an advance decision to refuse treatment (ADRT)). Of the other patients 13 had a DNAR, 5 had a documented PPC, 5 had a documented PPD and 2 patients had an ADRT. Of the 7 who died, only 2 had a PPD; both achieved their PPD.

This audit showed that while this is a small number of patients, this is a group with a high symptom burden at referral to palliative services. This suggests that palliative medicine has a role early in the patient journey. ACP was not fully completed in any audited patients indicating that this is an area requiring improvement.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.